Novoron Bioscience
San Diego
About Novoron Bioscience
Novoron Bioscience develops new therapeutic approaches to address neurological damage or disease in the central nervous system (CNS). Our novel LRP-focused science enables hope for treatment of conditions for which no current therapies exist. We’re advancing multiple biological therapeutics that treat pathologies of the CNS, including tauopathies (Alzheimer’s, CTE, TBI, etc.), acute spinal cord injury (orphan drug indication), and demyelinating conditions (multiple sclerosis, NMO, etc.).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $18.7M
- Funding stage: Seed
- Last round: Grant (Jan 2026)
- Website: novoron.com
- Phone: 2065011420
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/novoron-bioscience-114062 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.